Exclusive Content
Novo Nordisk’s Etavopivat Cracks Phase 3 Goals: A Potential New Standard of Care for Sickle Cell Disease
Novo Nordisk’s Etavopivat hits the mark in Pivotal Sickle Cell Study. Etavopivat, an oral, once-daily pyruvate kinase-R (PKR) activator displayed supercilious results showing 27%...
CDSCO Directs Stakeholders to Submit Prior Intimation for BA/BE Studies Online via Sugam Portal
In a significant regulatory development, the Central Drug Standard Control Organization, (CDSCO) has issued a circular mandating stakeholders to submit prior intimation for...
NIPER Mohali Partners with Novartis to Advance Industry–Academia Collaboration
By Dose Daily News Bureau
20th April, 2026
19:00 PM IST
The National Institute of Pharmaceutical Education and Research (NIPER) Mohali, has signed a formal collaboration...